2,6-Diiodo-4-((2-methyl-5-oxooxazol-4(5H)-ylidene)methyl)phenyl acetate

Catalog No. :
ACRZPW758
CAS No. :
93087-37-7
Molecular Formula :
C13H9I2NO4
Molecular Weight :
497.03

IUPAC Name:(E)-2,6-diiodo-4-((2-methyl-5-oxooxazol-4(5H)-ylidene)methyl)phenyl acetate

2,6-Diiodo-4-((2-methyl-5-oxooxazol-4(5H)-ylidene)methyl)phenyl acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,6-Diiodo-4-((2-methyl-5-oxooxazol-4(5H)-ylidene)methyl)phenyl acetate
IUPAC Name(E)-2,6-diiodo-4-((2-methyl-5-oxooxazol-4(5H)-ylidene)methyl)phenyl acetate
Molecular FormulaC13H9I2NO4
Molecular Weight497.03
SMILESO=C(OC(C)=N/1)C1=C/C2=CC(I)=C(OC(C)=O)C(I)=C2
InChI KeyJRVMVIJKFXPLNL-VZUCSPMQSA-N
Synonym4-[[4-(Acetyloxy)-3,5-diiodophenyl]methylene]-2-methyl-5(4H)-oxazolone;4-(4-Hydroxy-3,5-diiodobenzylidene)-2-Methyl-2-oxazolin-5-one Acetate;5(4H)-Oxazolone,4-[[4-(acetyloxy)-3,5-diiodophenyl]methylene]-2-methyl;4-[[4-(Acetyloxy)-3,5-diiodophenyl]methylene]-2-methyl-5(4H)-oxazolone (E/Z Mixture);(E)-2,6-diiodo-4-((2-methyl-5-oxooxazol-4(5H)-ylidene)methyl)phenyl acetate;4-[[4-(Acetyloxy)-3,5-diiodophenyl]methylene]-2-methyl-5(4H)-oxazolone_x000b_
CAS No.93087-37-7

Synthetic Route by SureRoute

1. ACRZPW758 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRZPW758 route product structure diagram
    ACRZPW75893087-37-7
Inquiry

2. ACRZPW758 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRZPW758 route product structure diagram
    ACRZPW75893087-37-7
Inquiry

Comments (0)